-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the process of R&D and production, we sometimes encounter some seemingly contradictory demands that are actually "just needed", such as requiring both high drug loading and small size of the tablet; both the tablet has sufficient hardness and the requirement for it.
Test conditions: 500mg tablets 88% mannitol, 10% paracetamol (300μm particle size), 2% lubricant GP-8 rotary tablet machine test results are shown in Figure 4, Figure 5
Test conditions:
Performance analysis
1.
2.
Test conditions: 500mg tablets 88% mannitol, 10% paracetamol (300μm particle size), 2% lubricant GP-8 rotary tablet machine test results are shown in Figure 2, Figure 3
3.
Test conditions: 500mg tablets 88% mannitol, 10% paracetamol (300μm particle size), 2% lubricant GP-8 rotary tablet machine test results are shown in Figure 4, Figure 5
It can be seen from the test results that Mannogem ® XL Opal has the following advantages:
① It is a general excipient
-
High compressibility, high solubility, high hardness and low resilience
-
Disintegration speed increased by 20-30%
-
Less lubricant required-will increase hardness, disintegration properties and sensory feel
-
Conducive to scale-up and production
Four, a broad formula design space
Mannogem ® XL Opal can produce tablets that meet the hardness requirements in a large span of pressure range, with good production adaptability and easy replacement of equipment, thus having a broader space for formulation designCase analysis of paracetamol orally disintegrating tablets
1.
Test conditions:
500mg tablets
Drug = 300μm acetaminophen (poor compressibility)
Prescription: 88% mannitol, 10% paracetamol API, 2% lubricant
GP-8 Rotary Tablet Press
test results:
Use MannogemXL Opal's high-hardness ODT tablets with high API drug loading
-
XL Opal has superior high drug loading capacity
-
XL Opal has higher tensile strength and lower friability
Under any API drug loading used in the experiment, the mannitol/starch co-processed ODT formulation did not reach the target friability
2.
Test conditions:
500mg tablets
Group 1: Co-processing of mannitol starch (10-78% mannitol content), 10% acetaminophen (particle size 300μm), 10% MCC, 2% lubricant;
Group 2: 10-88% mannitol XL Opal, 10% paracetamol, 2% lubricant;
GP-8 Rotary Tablet Press
The test results are shown in Figure 8 and Figure 9
Mannogem ® XL Opal can provide tablet formulations with sufficient hardness without the support of other auxiliary materials; competing products need to add 10% MCC to the formulation to meet the tablet requirements; competing products cannot achieve the target friability and hardness
.
3.
Formula of acetaminophen orally disintegrating tablets
Test conditions:
500mg tablets
Drug = 300μm acetaminophen (poor compressibility)
86% mannitol, 10% acetaminophen API, 2% crospovidone, 2% lubricant
GP-8 Rotary Tablet Press
test results:
From the above test results, it can be seen that Mannogem ® XL Opal can be used to prepare preparations that meet the requirements of orally disintegrating tablets; the preparations using competing mannitol-starch co-processed products have failed due to capping problems
.
It can be seen that using XL Opal can shorten the development time and increase the success rate
.
Summarize
Mannogem ® XL Opal has the same physical properties as the standard spray-dried mannitol used on the market, but the performance is enhanced
.
The superior performance of XL Opal is reflected in:
① Higher tensile strength
② Higher active ingredient carrying capacity
③ Shorten the development cycle and increase the production speed, and increase the success rate
-
Improve the yield of problem prescriptions-reduce capping and fragility related problems
-
Broad formula design space
-
Smaller stripping force can increase production capacity
-
Fewer auxiliary materials are needed to accelerate development at a lower cost
-
Shorten the disintegration time limit to reach the target disintegration time
-
No need for a lot of additional adhesive
④ Improve patient compliance
-
Faster disintegration, better patient compliance and sensory experience